Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Alkaline Phosphatase (AP) Substrate Test Kit
2026-09-28
The Alkaline Phosphatase (AP) Substrate Test Kit provides BCIP/NBT color development for visualizing alkaline phosphatase activity in Western blotting, immunohistochemistry, membrane assays, and selected iPS workflows. It is intended for scientific research use only and should not be used as a diagnostic, medical, fluorescent, or independently quantitative assay.
-
Oltipraz Workflows for Nrf2 and Liver Stress Research
2026-09-28
Use Oltipraz to test whether Nrf2-linked phase II enzyme induction changes cellular responses to xenobiotic or liver stress. This practical workflow connects the compound’s established enzyme-induction profile with a recent MASLD study, while clearly separating shared pathway rationale from untested treatment claims.
-
CDC42 Supports HBV Entry via NTCP and Macropinocytosis
2026-09-27
The study identifies CDC42 as a regulator of hepatitis B virus (HBV) entry through two separable effects: promoting NTCP delivery to the cell surface and supporting macropinocytosis. Its findings refine the current model of HBV uptake by distinguishing this CDC42-dependent route from clathrin-mediated endocytosis, while raising questions about how broadly the mechanism applies across infection models.
-
2-Thio-dCTP for Reliable DNA Assay Workflows
2026-09-26
Learn where 2-Thio-dCTP (SKU B8104) can support controlled DNA synthesis and where it should not be mistaken for a direct cell-viability reagent. This scenario-based guide covers experimental fit, handling, interpretation, and evidence-aware product selection.
-
5-Azacytidine and Viral Mimicry in PTEN-Deficient GBM
2026-09-25
5-Azacytidine is more than a DNA methylation tool: in PTEN-deficient glioblastoma, its immune effects depend on chromatin context. This article explains a recent EZH2-combination study and translates its findings into practical assay-design decisions.
-
Cyclosporin A B1922: Reliable Cell Assay Design
2026-09-25
A practical guide to using Cyclosporin A (SKU B1922) in cell viability, proliferation, and cytotoxicity workflows. It covers mechanism, solvent and storage considerations, starting conditions, interpretation limits, and evidence-based product selection.
-
Doxycycline in 3D Stem Cell Mechanobiology
2026-09-24
Use Doxycycline as a carefully controlled probe of metalloproteinase-dependent matrix remodeling—not as a stand-in for the rapid cell tumbling that drives stem cell fate in sliding hydrogels. This workflow pairs dose and vehicle controls with live imaging and differentiation readouts to help distinguish matrix effects from drug-related changes in cell health.
-
EPI-001 Workflows for AR Signaling Research
2026-09-24
EPI-001 lets researchers probe androgen receptor activity through its N-terminal domain, including signaling that may persist when the ligand-binding domain is absent. This workflow connects dose-response and transcriptional assays with migration readouts, while distinguishing established product data from proposed starting conditions and exploratory TNBC applications.
-
EPI-001 in TNBC: Reading ARv7 Evidence Carefully
2026-09-24
EPI-001 is an androgen receptor N-terminal domain inhibitor with a distinct research rationale in triple-negative breast cancer. This article examines what recent AR/ARv7 findings mean for interpreting migration and EMT assays—and where the evidence still stops short.
-
CFDA-SE for Proliferation and Cell Tracking
2026-09-23
CFDA-SE converts cell division into a measurable fluorescence-dilution history, supporting lymphocyte, fibroblast, NK-cell, bacterial, and migration studies. This practical guide pairs an optimized staining workflow with the CD38 surfaceome findings from nanobody-targeted TurboID to distinguish proliferation state from protein-proximity biology.
-
XFZYD Mechanisms in Nitroglycerin-Induced Migraine
2026-09-22
A 2026 study combined untargeted plasma metabolomics, brain transcriptomics, and molecular validation to investigate how Xuefu Zhuyu Decoction (XFZYD) acts in a rat model of nitroglycerin-induced chronic migraine. The analysis identified MAPK/ERK signaling as a central regulatory axis connecting vascular dysfunction, neurogenic inflammation, and the traditional blood-stasis phenotype.
-
Ionomycin free acid for Calcium-Driven Assays
2026-09-22
Ionomycin free acid provides a controlled way to elevate intracellular calcium for live-cell signaling, oocyte activation, and exploratory TNBC mechanism studies. This guide connects calcium ion transport workflows with the FAISL–FAK proteolysis model while emphasizing controls, timing, solvent management, and interpretation limits.
-
BV6 IAP Antagonist: Practical Cell-Death Workflows
2026-09-21
Build more informative apoptosis, radiation, immune-cell cytotoxicity, and disease-model experiments with BV6, an IAP antagonist and Smac mimetic. This guide connects pathway-aware assay design with practical dosing, solubility control, orthogonal readouts, and troubleshooting limits.
-
Rhodamine B for Drift Tracing and Fluorescence Assays
2026-09-21
Rhodamine B connects field-scale spray-drift mapping with controlled fluorescence workflows for microscopy and cell labeling. This guide shows how to standardize tracer preparation, quantify deposition, compare UAV and knapsack spraying, and troubleshoot signal variability without mistaking fluorescence for pesticide activity.
-
Bufuralol Hydrochloride in Translational β-Blockade
2026-09-20
Bufuralol hydrochloride is more than a conventional beta-blocker reference compound. Its non-selective receptor activity, partial intrinsic sympathomimetic activity, and membrane-stabilizing profile create a useful framework for linking cardiovascular pharmacology research with human-relevant pharmacokinetic models. This article integrates mechanistic interpretation, experimental controls, handling guidance, and human pluripotent stem cell-derived intestinal organoids to help translational teams design more informative β-adrenergic modulation studies.